Showing 1 - 20 results of 31 for search 'Ralf A Linker', query time: 0.06s
Refine Results
-
1
Navigating choice in multiple sclerosis management by Ralf A. Linker, Andrew Chan
Published 2019-02-01
Article -
2
Inflammation in multiple sclerosis by Stefanie Haase, Ralf A. Linker
Published 2021-04-01
Article -
3
The choline pathway as a strategy to promote central nervous system (CNS) remyelination by Thomas Skripuletz, Ralf A Linker, Martin Stangel
Published 2015-01-01
Article -
4
CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial by Viktoria Gudi, Paweł Grieb, Ralf A Linker, Thomas Skripuletz
Published 2023-01-01
Article -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany by Tjalf Ziemssen, Stephan Richter, Mathias Mäurer, Mathias Buttmann, Boris Kreusel, Anne-Maria Poehler, Maren Lampl, Ralf A. Linker
Published 2022-06-01
Article -
14
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation by Anna Hammer, Anne Schliep, Stefanie Jörg, Aiden Haghikia, Ralf Gold, Markus Kleinewietfeld, Dominik N. Müller, Ralf A. Linker
Published 2017-09-01
Article -
15
-
16
-
17
-
18
Index event of cerebral amyloid angiopathy (CAA) determines long-term prognosis and recurrent events (retrospective analysis and clinical follow-up) by Andrea Wagner, Christiane Groetsch, Sibylle Wilfling, Karl-Michael Schebesch, Mustafa Kilic, Marjan Nenkov, Christina Wendl, Ralf A. Linker, Felix Schlachetzki
Published 2021-09-01
Article -
19
-
20
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis by Kathrin S. Utz, Jana Hoog, Andreas Wentrup, Sebastian Berg, Alexandra Lämmer, Britta Jainsch, Anne Waschbisch, De-Hyung Lee, Ralf A. Linker, Thomas Schenk
Published 2014-11-01
Article